Please check your internet connection and try again.
# Mega CV
## Overview
Mega CV is a brand-name fixed-dose combination antibiotic containing **Amoxicillin** (aminopenicillin) and **Clavulanate Potassium** (a beta-lactamase inhibitor). It is used to extend the spectrum of amoxicillin to include beta-lactamase-producing organisms.
## Primary Indications
* Community-acquired pneumonia
* Acute bacterial sinusitis
* Acute otitis media
* Skin and soft tissue infections
* Urinary tract infections
* Bite wounds
## Adult Dosing
* **Mild to Moderate Infections:** 500 mg/125 mg orally every 8 hours OR 875 mg/125 mg orally every 12 hours.
* **Severe Infections:** 875 mg/125 mg orally every 8 hours.
* **Maximum Dose:** Based on the amoxicillin component; avoid exceeding standard maximum daily limits for amoxicillin (typically 4g/day).
## Pediatric Dosing
* **General Dosing:** Based on the amoxicillin component (usually 20–45 mg/kg/day divided every 8–12 hours, depending on infection severity).
* **Acute Otitis Media:** Often dosed at 90 mg/kg/day (amoxicillin component) divided every 12 hours using the 7:1 ratio formulation to minimize clavulanate exposure and diarrhea risk.
* **Maximum Dose:** Do not exceed adult maximums. Pediatric liquid formulations are concentration-specific; verify the ratio before dispensing.
## Dose Adjustments
* **Renal Impairment:** Dose adjustments are required for CrCl < 30 mL/min. Avoid the 875 mg tablet in patients with severe renal impairment (CrCl < 30 mL/min) as these formulations are fixed-dose and cannot be adjusted for renal clearance.
* **Hepatic Impairment:** Use with caution; monitor liver function periodically.
## Contraindications
* History of amoxicillin/clavulanate-associated cholestatic jaundice or hepatic dysfunction.
* Severe hypersensitivity (anaphylaxis) to any penicillin or beta-lactam.
## Adverse Effects
* **Gastrointestinal:** Diarrhea (very common; often reduced by taking with food), nausea, vomiting.
* **Hepatic:** Elevated transaminases (ALT/AST), cholestatic jaundice (rare).
* **Dermatologic:** Rash (typically non-allergic maculopapular rash, especially in patients with mononucleosis).
* **Hypersensitivity:** Urticaria, angioedema, anaphylaxis.
## Key Drug Interactions
* **Warfarin:** May increase INR and bleeding risk; monitor closely during and after therapy.
* **Methotrexate:** Amoxicillin may decrease renal clearance of methotrexate, increasing risk of toxicity.
* **Oral Contraceptives:** May decrease efficacy (though clinical evidence is mixed, suggest backup barrier methods).
* **Probenecid:** Decreases renal excretion of amoxicillin, increasing serum levels.
## Monitoring
* **Renal/Hepatic:** Periodic LFTs and SCr for prolonged therapy (over 14 days).
* **Symptoms:** Monitor for signs of *C. difficile*-associated diarrhea or allergic reactions.
## Clinical Pearls
* **Clavulanate Ratio:** The ratio of amoxicillin to clavulanate varies by tablet strength. Always verify the specific mg/mg strength to ensure safe dosing.
* **Food Intake:** Administer at the start of a meal to improve tolerability and minimize GI side effects.
* **Suspension Storage:** Liquid suspensions typically require refrigeration and are stable for 10 days once reconstituted.
* **Pseudomembranous Colitis:** As with most antibiotics, inform patients to seek care if they develop severe, persistent, or bloody diarrhea.
***
*Disclaimer: This information is for educational purposes only. Clinical practice guidelines and local drug formularies vary. Always verify current prescribing information, patient-specific renal function, and weight-based calculations via reliable professional resources (e.g., Lexicomp, UpToDate) before prescribing or administering medication.*
